<code id='389F504DF0'></code><style id='389F504DF0'></style>
    • <acronym id='389F504DF0'></acronym>
      <center id='389F504DF0'><center id='389F504DF0'><tfoot id='389F504DF0'></tfoot></center><abbr id='389F504DF0'><dir id='389F504DF0'><tfoot id='389F504DF0'></tfoot><noframes id='389F504DF0'>

    • <optgroup id='389F504DF0'><strike id='389F504DF0'><sup id='389F504DF0'></sup></strike><code id='389F504DF0'></code></optgroup>
        1. <b id='389F504DF0'><label id='389F504DF0'><select id='389F504DF0'><dt id='389F504DF0'><span id='389F504DF0'></span></dt></select></label></b><u id='389F504DF0'></u>
          <i id='389F504DF0'><strike id='389F504DF0'><tt id='389F504DF0'><pre id='389F504DF0'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:entertainment    Page View:828
          One Medical and Amazon Care apps displayed on a phone. -- health tech coverage from STAT.
          Adobe

          The graveyard is littered with Amazon’s bets in health care: wearables, Care, the ill-fated Haven. Out of their ashes, a new health strategy has emerged at the tech goliath. And while its leaders insist that Amazon has no grand plan for health care, a flurry of moves in the last year offer a glimpse into its ambitions at a time when they seem more cohesive than ever.

          “We have learned a lot in the years that we’ve been dabbling in health care,” said Sunita Mishra, chief medical officer for Amazon Health Services. “And it’s now made us more confident that we’re on the right track.”

          advertisement

          STAT spoke to four of Amazon’s chief medical officers about the company’s recent plays and how they fit into the company’s health care goals. Last November, it launched Amazon Clinic, a marketplace for virtual-only appointments for straightforward medical needs like pink eye, UTIs, and birth control. Two months later, its Amazon Pharmacy business launched RxPass, a $5 generic medication discount program, setting it up as a Walmart rival. And in February, it closed the acquisition of hybrid primary care company One Medical in a deal valued at $3.9 billion.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          Ahead of JPM, here's who's profiting most in health care
          Ahead of JPM, here's who's profiting most in health care

          AdobeForalltheflaktheyget,thecountry’sfourbiggestpharmacybenefitmanagersreportedasurprisinglytameave

          read more
          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more

          As the dark side of IVF slowly comes into focus, even more transparency is needed

          AselectionofIVFhormonebottlesandsyringesattheScienceMuseuminLondon,England.LeonNeal/GettyImagesIwas1